Soren Andersen
Overview
Explore the profile of Soren Andersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomsen H, Lausvig N, Pipper C, Andersen S, Damgaard L, Emerson S, et al.
Stat Med
. 2024 Jun;
43(18):3417-3431.
PMID: 38852994
We investigate the familywise error rate (FWER) for time-to-event endpoints evaluated using a group sequential design with a hierarchical testing procedure for secondary endpoints. We show that, in this setup,...
2.
Nielsen E, Andersen S, Brand C, Ditlevsen S
PLoS One
. 2022 Jun;
17(6):e0257750.
PMID: 35709155
This paper examines how to reduce the number of control animals in preclinical hyperinsulemic glucose clamp studies if we make use of information on historical studies. A dataset consisting of...
3.
Kjalke M, Kjelgaard-Hansen M, Andersen S, Hilden I
J Thromb Haemost
. 2021 Apr;
19(7):1687-1696.
PMID: 33819375
Background: The anti-tissue factor plasma inhibitor monoclonal antibody concizumab is under clinical investigation for subcutaneous prophylaxis of hemophilia A/B (HA/HB) with or without inhibitors. Breakthrough bleeds while on concizumab prophylaxis...
4.
Ponce de Leon B, Andersen S, Karstoft K, Elklit A
Eur J Psychotraumatol
. 2018 May;
9(1):1443672.
PMID: 29707166
: This study investigated whether pre-deployment dissociation was associated with previously identified post-traumatic stress disorder (PTSD) symptom trajectories from before to 2.5 years after military deployment. Furthermore, it examined whether...
5.
Willis T, Hollingsworth K, Coombs A, Sveen M, Andersen S, Stojkovic T, et al.
PLoS One
. 2014 Mar;
9(2):e90377.
PMID: 24587344
We conducted a prospective multinational study of muscle pathology using magnetic resonance imaging (MRI) in patients with limb-girdle muscular dystrophy 2I (LGMD2I). Thirty eight adult ambulant LGMD2I patients (19 male;...
6.
Willis T, Hollingsworth K, Coombs A, Sveen M, Andersen S, Stojkovic T, et al.
PLoS One
. 2013 Aug;
8(8):e70993.
PMID: 23967145
Background: Outcome measures for clinical trials in neuromuscular diseases are typically based on physical assessments which are dependent on patient effort, combine the effort of different muscle groups, and may...
7.
Madsen L, Knauf J, Gotfredsen C, Pilling A, Sjogren I, Andersen S, et al.
Endocrinology
. 2012 Jan;
153(3):1538-47.
PMID: 22234463
Liraglutide and exenatide are glucagon-like peptide receptor (GLP-1R) agonists used in the treatment of type 2 diabetes. Both molecules have been associated with the development of thyroid C-cell tumors after...
8.
Stenderup K, Rosada C, Alifrangis L, Andersen S, Dam T
Exp Dermatol
. 2011 Mar;
20(5):441-4.
PMID: 21426413
Psoriasis xenograft transplantation models where human skin is transplanted onto immune-deficient mice are generally accepted in psoriasis research. Over the last decade, they have been widely employed to screen for...
9.
Viuff D, Andersen S, Sorensen B, Lethagen S
Thromb Res
. 2010 Jun;
126(2):144-9.
PMID: 20542542
Introduction: There is no established laboratory method that can predict the most optimal dose of bypassing agents for treatment of haemophilia A. The objectives of the study was to develop...
10.
Knudsen L, Madsen L, Andersen S, Almholt K, DE Boer A, Drucker D, et al.
Endocrinology
. 2010 Mar;
151(4):1473-86.
PMID: 20203154
Liraglutide is a glucagon-like peptide-1 (GLP-1) analog developed for type 2 diabetes. Long-term liraglutide exposure in rodents was associated with thyroid C-cell hyperplasia and tumors. Here, we report data supporting...